Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Hypersensitivity Reaction

Free Subscription Articles published in Allergy Asthma Proc Retrieve available abstracts of 225 articles: HTML format

Single Articles

May 2024
1. STRANZL T, Bernstein DI, Matsuoka T, Durham S, et al
   Consistent efficacy and safety of sublingual immunotherapy tablets across allergens and geographic regions.
   Allergy Asthma Proc. 2024 May 17. doi: 10.2500/aap.2024.45.240020.
   PubMed     Abstract available
   
   
   
2. GENIS C, Sengul Emeksiz Z, Buyuk Yaylatokgil S, Ginis T, et al
   Successful rapid liposomal amphotericin B desensitization in pediatric case series.
   Allergy Asthma Proc. 2024;45:201-206.
   PubMed     Abstract available
   
   
   
3. BELLANTI JA, Settipane RA
   Exploring the spectrum of allergic disorders that continue to challenge the Allergist-Immunologist: From hereditary angioedema to metal implant allergy.
   Allergy Asthma Proc. 2024;45:143-146.
   PubMed    
   
   
   
4. MARI DC, Banks TA
   Removing penicillin allergy label in a hospitalized adolescent with a remote penicillin and recent cephalosporin allergy.
   Allergy Asthma Proc. 2024;45:207-210.
   PubMed     Abstract available
   
   
   
5. KATIAL JM, Hoyte FCL, Khatiwada A, Katial RK, et al
   Allergen skin test responses in broad U.S. asthma population in those with and without rhinitis.
   Allergy Asthma Proc. 2024;45:158-165.
   PubMed     Abstract available
   
   
   
6. WANG K, Zhang Y, Wan L, Li J, et al
   Comparison of clinical traits for seasonal and perennial allergic rhinitis during allergen exposure.
   Allergy Asthma Proc. 2024;45:173-179.
   PubMed     Abstract available
   
   
   
7. RADOJICIC C, Anderson J
   Hereditary angioedema with normal C1 esterase inhibitor: Current paradigms and clinical dilemmas.
   Allergy Asthma Proc. 2024;45:147-157.
   PubMed     Abstract available
   
   
   
8. BRUNETTO S, Gammeri L, Buta F, Gangemi S, et al
   Hymenoptera venom immunotherapy: Safety and efficacy of an accelerated induction regimen with depot aluminum adsorbed extracts.
   Allergy Asthma Proc. 2024;45:195-200.
   PubMed     Abstract available
   
   
   
9. AYDIN O, Akbay NO, Buyukatalay ZC, Arslan F, et al
   Evaluation of sinonasal involvement in patients with asthma and chronic obstructive pulmonary disease.
   Allergy Asthma Proc. 2024;45:166-172.
   PubMed     Abstract available
   
   
   
10. TALIERCIO MJ, Alnabulsi RK, Uppal PA, Shaw IM, et al
    Metal implant allergy: A retrospective cohort analysis at a university allergy practice.
    Allergy Asthma Proc. 2024;45:186-194.
    PubMed     Abstract available
    
    
    March 2024
11. SHIN S, Jang S, Kim J, Song J, et al
    Initial updosing phase of oral immunotherapy improves quality of life and psychological burden in parents of children with food allergy.
    Allergy Asthma Proc. 2024;45:128-136.
    PubMed     Abstract available
    
    
    
12. BELLANTI JA, Settipane RA
    Allergic diseases in children: A continuing challenge for the Allergist-Immunologist.
    Allergy Asthma Proc. 2024;45:81-83.
    PubMed    
    
    
    
13. BALOH CH, Hsu JT
    Oral immunotherapy with sunflower seed butter and a review of seed allergy.
    Allergy Asthma Proc. 2024;45:137-140.
    PubMed     Abstract available
    
    
    
14. RUDSENSKE NE, Perkins JB
    Assessing severity of COVID-19 and the development of multi system inflammatory syndrome in children (MIS-C) in pediatric patients with atopic disease.
    Allergy Asthma Proc. 2024;45:92-96.
    PubMed     Abstract available
    
    
    
15. NAVALPAKAM A, Thanaputkaiporn N, Aijja C, Mongkonsritragoon W, et al
    Impact of steroids on the immune profiles of children with asthma living in the inner-city.
    Allergy Asthma Proc. 2024;45:100-107.
    PubMed     Abstract available
    
    
    
16. KAZANCIOGLU A, Konuralp I, Sahiner UM, Soyer O, et al
    Understanding of lipid transfer protein sensitization patterns and its clinical significance in children.
    Allergy Asthma Proc. 2024;45:120-127.
    PubMed     Abstract available
    
    
    
17. KELLER L, Perera EK, Bindon B, Khatiwada A, et al
    Total IgE as a biomarker of omalizumab response in chronic spontaneous urticaria: A meta-analysis.
    Allergy Asthma Proc. 2024;45:97-99.
    PubMed     Abstract available
    
    
    
18. PARK M, Yum HY, Bae JM, Lee S, et al
    Factors influencing the quality of life in children with atopic dermatitis in Korea: A multicenter cross-sectional study.
    Allergy Asthma Proc. 2024;45:112-119.
    PubMed     Abstract available
    
    
    
19. BERNSTEIN JA, Wymer LJ, Nye M, Vesper SJ, et al
    The relationship between childhood atopic dermatitis and asthma in an under resourced community.
    Allergy Asthma Proc. 2024;45:108-111.
    PubMed     Abstract available
    
    
    January 2024
20. TACHDJIAN R, Savic S, Fridman M, Frade JP, et al
    Real-world reporting rates of administration-site reactions with on-demand treatment of hereditary angioedema attacks.
    Allergy Asthma Proc. 2024;45:37-43.
    PubMed     Abstract available
    
    
    
21. BELLANTI JA, Settipane RA
    Unraveling allergic, pseudoallergic, and idiosyncratic complexities of hypersensitivity reactions to NSAIDs.
    Allergy Asthma Proc. 2024;45:1-4.
    PubMed    
    
    
    
22. LUMRY WR, Bernstein JA, Li HH, Levy DS, et al
    An expert panel's review on patients with hereditary angioedema switching from attenuated androgens to oral prophylactic therapy.
    Allergy Asthma Proc. 2024;45:44-49.
    PubMed     Abstract available
    
    
    
23. LIM PPC, Moore LN, Minich NM, Wessell KR, et al
    Inpatient allergy delabeling of pediatric patients with low-risk penicillin allergy status through direct oral amoxicillin challenge.
    Allergy Asthma Proc. 2024;45:61-69.
    PubMed     Abstract available
    
    
    
24. LUNDBERG M, Maurer R, Tchekmedyian R, Mullur J, et al
    Validation of a questionnaire assessing smell loss in an international aspirin-exacerbated respiratory disease population.
    Allergy Asthma Proc. 2024;45:5-13.
    PubMed     Abstract available
    
    
    
25. CHEN X, Luo H, Yan W, Tang K, et al
    Real-world effectiveness and predictors of super-responders to dupilumab in a Chinese uncontrolled asthma cohort.
    Allergy Asthma Proc. 2024;45:e14-e22.
    PubMed     Abstract available
    
    
    
26. SHIM JS, Kim MH, Cho YJ
    Risk of asthma and/or wheezing in obese individuals with or without metabolic syndrome: From the Korea National Health and Nutrition Examination Survey data.
    Allergy Asthma Proc. 2024;45:e1-e8.
    PubMed     Abstract available
    
    
    
27. BOURGOYNE K, Sampognaro L, Bhat A, Valdes Camacho J, et al
    Health disparities in hymenoptera venom allergy management.
    Allergy Asthma Proc. 2024;45:50-52.
    PubMed     Abstract available
    
    
    
28. NELSON HS, Bernstein DI, Biedermann T, Nolte H, et al
    Sublingual immunotherapy tablets in monosensitized and polysensitized adults with allergic rhinoconjunctivitis.
    Allergy Asthma Proc. 2024;45:33-36.
    PubMed     Abstract available
    
    
    
29. REBROVA S, Emelyanov A, Sergeeva G, Korneenkov A, et al
    Markers of eosinophilic airway inflammation in patients with asthma and allergic rhinitis.
    Allergy Asthma Proc. 2024;45:e9-e13.
    PubMed     Abstract available
    
    
    
30. 
    Abstracts presented at the Eastern Allergy Conference June 1-4, 2023, Palm Beach, Florida.
    Allergy Asthma Proc. 2024;45:75-78.
    PubMed    
    
    
    
31. HODGES M, Freigeh GE, Troost J, Baptist AP, et al
    Assessment of mask use on oxygen saturation in adults and children with asthma.
    Allergy Asthma Proc. 2024;45:24-32.
    PubMed     Abstract available
    
    
    
32. ARIKOGLU T, Tokmeci N, Demirhan A, Kont Ozhan A, et al
    Evaluation of different protocols for classification of pediatric hypersensitivity reactions to nonsteroidal anti-inflammatory drugs: Children with underlying allergic disease should be a separate subgroup.
    Allergy Asthma Proc. 2024;45:14-23.
    PubMed     Abstract available
    
    
    
33. MAGEN E, Merzon E, Green I, Golan-Cohen A, et al
    A case-control study for comorbidity and laboratory factors associated with food-induced anaphylaxis.
    Allergy Asthma Proc. 2024;45:53-60.
    PubMed     Abstract available
    
    
    November 2023
34. CAN A, Tuzer OC
    The evaluation of melatonin levels in chronic spontaneous urticaria: A case control study.
    Allergy Asthma Proc. 2023;44:e29-e35.
    PubMed     Abstract available
    
    
    
35. HANANIA NA, Settipane RA, Khoury S, Shaikh A, et al
    Adding tiotropium or long-acting beta2-agonists to inhaled corticosteroids: Asthma-related exacerbation risk and healthcare resource utilization.
    Allergy Asthma Proc. 2023;44:413-421.
    PubMed     Abstract available
    
    
    
36. BELLANTI JA, Settipane RA
    Navigating the uncharted waters of chronic urticaria: A perplexing challenge for the allergist-immunologist.
    Allergy Asthma Proc. 2023;44:379-381.
    PubMed    
    
    
    
37. NELSON HS
    Allergy immunotherapy for allergic fungal respiratory diseases.
    Allergy Asthma Proc. 2023;44:395-401.
    PubMed     Abstract available
    
    
    
38. KULUMBEGOV B, Chikovani T, Gotua M, Kikodze N, et al
    Interleukin-33, endothelin-1, and inflammatory parameters in chronic spontaneous urticaria.
    Allergy Asthma Proc. 2023;44:429-435.
    PubMed     Abstract available
    
    
    
39. KARABAG CITLAK H, Azkur D, Kavas Yildiz Y, Demirel AC, et al
    Cold-induced urticaria in children: A multicenter, retrospective cohort study.
    Allergy Asthma Proc. 2023;44:e36-e43.
    PubMed     Abstract available
    
    
    
40. KARCHER H, Schoenberger M, Rayban T, Kelly C, et al
    Impact of COVID-19 measures on exacerbation rates and healthcare visits in US asthma patients.
    Allergy Asthma Proc. 2023;44:422-428.
    PubMed     Abstract available
    
    
    
41. WALLACE DV
    Evaluation and management of chronic cough in adults.
    Allergy Asthma Proc. 2023;44:382-394.
    PubMed     Abstract available
    
    
    
42. XU SY, Lv HQ, Zeng CL, Peng YJ, et al
    Prevalence and bidirectional association between rhinitis and urticaria: A systematic review and meta-analysis.
    Allergy Asthma Proc. 2023;44:402-412.
    PubMed     Abstract available
    
    
    September 2023
43. BRENNAN J, Yamada K, Al-Shaikhly T, Ghaffari G, et al
    Diagnosis of eosinophilic esophagitis in patients with dysphagia during the Coronavirus Disease 2019 (COVID-19) pandemic.
    Allergy Asthma Proc. 2023;44:333-339.
    PubMed     Abstract available
    
    
    
44. KHAN NS, Rubin E, McKenna B, Palowitch BL, et al
    The COVID-19 impact on severe uncontrolled asthma costs and biologic use.
    Allergy Asthma Proc. 2023;44:340-344.
    PubMed     Abstract available
    
    
    
45. ISLAMOGLU C, Arman Bilir O, Ok Bozkaya I, Demirel AC, et al
    Characteristics and management of hypersensitivity reactions with rabbit anti-thymocyte globulin in pediatric patients.
    Allergy Asthma Proc. 2023;44:e22-e28.
    PubMed     Abstract available
    
    
    
46. BELLANTI JA
    The PANDAS/PANS disorders. Is it time for more allergist-immunologists to get involved?
    Allergy Asthma Proc. 2023;44:296-305.
    PubMed     Abstract available
    
    
    
47. WANG WT, Li CY, Chang YT, Bai YM, et al
    Proton-pump inhibitors are associated with an increased risk of asthma: A nationwide nested case-control study.
    Allergy Asthma Proc. 2023;44:345-353.
    PubMed     Abstract available
    
    
    
48. TURGAY YAGMUR I, Kulhas Celik I, Yilmaz Topal O, Toyran M, et al
    Development of anaphylaxis upon oral food challenge and drug provocation tests in pediatric patients.
    Allergy Asthma Proc. 2023;44:326-332.
    PubMed     Abstract available
    
    
    
49. BELLANTI JA, Settipane RA
    The challenge of neurologic disease for the allergist/immunologist.
    Allergy Asthma Proc. 2023;44:293-295.
    PubMed    
    
    
    
50. FENG H, Luo N, Xiong X, Wu Y, et al
    Prevalence of food allergy in the Chinese population: A systematic review and meta-analysis of population-based studies.
    Allergy Asthma Proc. 2023;44:315-325.
    PubMed     Abstract available
    
    
    
51. NSOULI TM
    New insights in the optimal diagnosis and management of food allergy.
    Allergy Asthma Proc. 2023;44:306-314.
    PubMed     Abstract available
    
    
    
52. GAJEWSKI AJ, Palka JM, Raitt JM, Agarwal CD, et al
    Association of serotonin reuptake inhibitors with asthma control.
    Allergy Asthma Proc. 2023;44:354-360.
    PubMed     Abstract available
    
    
    
53. GABRESKI LN, Schuldt MM, Adams KE
    A masquerade of recurrent anaphylaxis.
    Allergy Asthma Proc. 2023;44:374-376.
    PubMed     Abstract available
    
    
    July 2023
54. RIEDL MA, Hinds DR, Prince PM, Alvord TM, et al
    Healthcare utilization of patients with hereditary angioedema treated with lanadelumab and subcutaneous C1-inhibitor concentrate.
    Allergy Asthma Proc. 2023;44:275-282.
    PubMed     Abstract available
    
    
    
55. HU H, Hu X, Wang Z, Gao L, et al
    Clinical value of serum soluble receptor for advanced glycation end products in evaluating the condition of patients with bronchial asthma.
    Allergy Asthma Proc. 2023;44:258-264.
    PubMed     Abstract available
    
    
    
56. TOSCA MA, Ciprandi G
    Oral food challenge to milk is still necessary to diagnose cow's milk allergy and should be conducted in adequate facilities.
    Allergy Asthma Proc. 2023;44:e2.
    PubMed    
    
    
    
57. PETERS AT, Wagenmann M, Bernstein JA, Khan AH, et al
    Dupilumab efficacy in patients with chronic rhinosinusitis with nasal polyps with and without allergic rhinitis.
    Allergy Asthma Proc. 2023;44:265-274.
    PubMed     Abstract available
    
    
    
58. BRAKE DR, Yaman RN, Camargo AR, Marks LA, et al
    Meteorological and environmental factors that impact pollen counts, allergenicity, and thresholds: A scoping review.
    Allergy Asthma Proc. 2023;44:229-236.
    PubMed     Abstract available
    
    
    
59. CIHANBEYLERDEN M, Can Bostan O, Tuncay G, Safak C, et al
    Evaluation of disease control after SARS-CoV-2 infection or vaccination in patients with NSAID-exacerbated airway disease.
    Allergy Asthma Proc. 2023;44:e3-e10.
    PubMed     Abstract available
    
    
    
60. WANG J, Yang Y, Cao J, Song X, et al
    Total serum immunoglobulin E (IgE) as an effective predictor for identifying allergic asthma in childhood asthma.
    Allergy Asthma Proc. 2023;44:252-257.
    PubMed     Abstract available
    
    
    
61. KUAI S, Zhao P
    Association of EDN levels in patients with asthma and correlation with FEV(1)%: A meta-analysis.
    Allergy Asthma Proc. 2023;44:244-251.
    PubMed     Abstract available
    
    
    
62. ACQUISTO NM, Bodkin RP, Vabishchevich Y, Falkowski MW, et al
    Epinephrine autoinjector prescribing following anaphylaxis presentation to the emergency department.
    Allergy Asthma Proc. 2023;44:283-290.
    PubMed     Abstract available
    
    
    May 2023
63. FRENKEL LD, Gaur S, Bellanti JA
    The third pandemic: The respiratory syncytial virus landscape and specific considerations for the allergist/immunologist.
    Allergy Asthma Proc. 2023 May 26. doi: 10.2500/aap.2023.44.230030.
    PubMed     Abstract available
    
    
    
64. BELLANTI JA, Settipane RA
    A tribute to allergy and immunology fellowship training program directors and to the fellows they train.
    Allergy Asthma Proc. 2023;44:155-157.
    PubMed    
    
    
    
65. WITTE J, Singh H, Turk Y, van Huisstede A, et al
    Effect of bariatric surgery on lung function and asthma control after 8 years of follow-up.
    Allergy Asthma Proc. 2023;44:165-170.
    PubMed     Abstract available
    
    
    
66. CAN A, Coskun R, Karabacak DE, Tuzer OC, et al
    Common but neglected problem in chronic spontaneous urticaria: Sleep disturbance.
    Allergy Asthma Proc. 2023;44:179-185.
    PubMed     Abstract available
    
    
    
67. DURANT JE, Temple CA, Schachner BI, Zippi Z, et al
    Demographics and characteristics of leadership at allergy and immunology fellowships in the U.S. as of 2022.
    Allergy Asthma Proc. 2023;44:158-164.
    PubMed     Abstract available
    
    
    
68. CELIK GE, Guloglu Karatas D, Aydin O, Dogu F, et al
    Diagnostic utility of basophil CD203c expression in beta-lactam allergy.
    Allergy Asthma Proc. 2023;44:200-207.
    PubMed     Abstract available
    
    
    
69. JUNG JH, Park M, Kim GE, Kim JD, et al
    TEV/FEV(3) as a coherent metric of small airway dysfunction in childhood asthma.
    Allergy Asthma Proc. 2023;44:171-178.
    PubMed     Abstract available
    
    
    
70. SABIT B, Ozdemir O, Kose E
    Comparison of commercial allergen extract with various milk products of skin prick tests in diagnosing cow's milk protein allergy.
    Allergy Asthma Proc. 2023;44:193-199.
    PubMed     Abstract available
    
    
    
71. AL S, Asilsoy S, Atay O, Kangalli O, et al
    Transepidermal water loss in allergic diseases.
    Allergy Asthma Proc. 2023;44:186-192.
    PubMed     Abstract available
    
    
    
72. 
    Abstracts published from the New England Society of Allergy Annual Fall Meeting, October 22-23, 2022, Portsmouth, NH.
    Allergy Asthma Proc. 2023;44:213.
    PubMed    
    
    
    
73. 
    Presented at the Western Society of Allergy, Asthma & Immunology, February 5-9, 2023, Kamuela, Hawaii.
    Allergy Asthma Proc. 2023;44:214-215.
    PubMed    
    
    
    
74. 
    Abstracts published from the New England Society of Allergy Annual Fall Meeting, October 22-23, 2022, Portsmouth, NH.
    Allergy Asthma Proc. 2023;44:213.
    PubMed    
    
    
    
75. 
    Presented at the Western Society of Allergy, Asthma & Immunology, February 5-9, 2023, Kamuela, Hawaii.
    Allergy Asthma Proc. 2023;44:214-215.
    PubMed    
    
    
    March 2023
76. JHAVERI PB, Lambert KA, Bogale K, Lehman E, et al
    Salivary microRNAs in pediatric eosinophilic esophagitis.
    Allergy Asthma Proc. 2023;44:145-152.
    PubMed     Abstract available
    
    
    
77. BELLANTI JA, Settipane RA
    The complexities of allergic diseases continue to challenge the allergist-immunologist.
    Allergy Asthma Proc. 2023;44:87-89.
    PubMed    
    
    
    
78. HU H, Dai J, Zheng X, Wu J, et al
    The relationship of D. pteronyssinus allergic component sIgE and sIgG(4) in house dust mite allergic rhinitis or/and allergic asthma patients.
    Allergy Asthma Proc. 2023;44:100-105.
    PubMed     Abstract available
    
    
    
79. CHRISTIANSEN SC, Lopes Veronez C, Smith TD, Riedl MA, et al
    Hereditary Angioedema: Impact of COVID-19 pandemic stress upon disease related morbidity and well-being.
    Allergy Asthma Proc. 2023;44:115-121.
    PubMed     Abstract available
    
    
    
80. SINGH U, Bernstein JA
    Can clinical characteristics differentiate patients with unexplained chronic cough from patients with asthma and COPD?
    Allergy Asthma Proc. 2023;44:90-99.
    PubMed     Abstract available
    
    
    
81. CAN A, Karabacak DE, Yalcin BK, Demir S, et al
    How important is patch testing with dental materials in real-life clinical practice?
    Allergy Asthma Proc. 2023;44:136-144.
    PubMed     Abstract available
    
    
    
82. CELIK GE, Karakaya G, Erkekol FO, Dursun AB, et al
    Comparison of 300 mg versus 600 mg daily maintenance doses of aspirin treatment after desensitization in N-ERD: A three-year multicentre experience.
    Allergy Asthma Proc. 2023;44:106-114.
    PubMed     Abstract available
    
    
    
83. VITALPUR G, Lahood R, Kussin M, Koenigsberg R, et al
    Impact of penicillin allergy labels among pneumonia admissions at an academic children's center.
    Allergy Asthma Proc. 2023;44:130-135.
    PubMed     Abstract available
    
    
    
84. MAGEN E, Merzon E, Green I, Magen I, et al
    A comparative study of chronic spontaneous urticaria and chronic mast cell mediated angioedema.
    Allergy Asthma Proc. 2023;44:122-129.
    PubMed     Abstract available
    
    
    January 2023
85. STAMATAKI S, Georgountzou A, Papadopoulos NG, Taka S, et al
    Atopic children are more susceptible to viral respiratory infection at the age of 2-5 years old.
    Allergy Asthma Proc. 2023;44:64-70.
    PubMed     Abstract available
    
    
    
86. DUFFEY H, Leonard J, Mistry RD
    Variation in diagnosis and management of allergic reactions among emergency medicine and allergy immunology providers.
    Allergy Asthma Proc. 2023;44:51-58.
    PubMed     Abstract available
    
    
    
87. ZHAO B, Zheng H, Yang T, Zheng R, et al
    Eosinophilic granulomatosis with polyangiitis in allergic asthma: Efforts to make early diagnosis possible.
    Allergy Asthma Proc. 2023;44:59-63.
    PubMed     Abstract available
    
    
    
88. TRIPATHI SH, Corr A, Kumar A, Ungerer H, et al
    SNOT-22 scores after 6 months of aspirin therapy are predictive of long-term quality of life in AERD.
    Allergy Asthma Proc. 2023;44:78-80.
    PubMed     Abstract available
    
    
    
89. BELLANTI JA, Settipane RA
    Allergy and immunology: At the crossroad of inflammation and disease.
    Allergy Asthma Proc. 2023;44:1-2.
    PubMed    
    
    
    
90. BAHNA SL
    The impact of modernization on allergy and asthma development.
    Allergy Asthma Proc. 2023;44:15-23.
    PubMed     Abstract available
    
    
    
91. ZHANG MS, Huston J, Petrov A, Fajt ML, et al
    Peanut allergy in an adult following cardiac transplant from a non-atopic donor.
    Allergy Asthma Proc. 2023;44:81-84.
    PubMed     Abstract available
    
    
    
92. KIM H, Alizadehfar R, Alqurashi W, Ellis AK, et al
    Epinephrine autoinjectors: individualizing device and dosage to optimize anaphylaxis management in the community setting.
    Allergy Asthma Proc. 2023;44:45-50.
    PubMed     Abstract available
    
    
    
93. DO TT, Canty EA, Joshi SR
    Current and future management of chronic spontaneous urticaria and chronic inducible urticaria.
    Allergy Asthma Proc. 2023;44:3-14.
    PubMed     Abstract available
    
    
    
94. NAVALPAKAM A, Thanaputkaiporn N, Poowuttikul P
    Anaphylaxis: Long-term management and resources.
    Allergy Asthma Proc. 2023;44:35-44.
    PubMed     Abstract available
    
    
    
95. BRAVO-SOLARTE DC, Garcia-Guaqueta DP, Chiarella SE
    Asthma in pregnancy.
    Allergy Asthma Proc. 2023;44:24-34.
    PubMed     Abstract available
    
    
    November 2022
96. NIEMINEN O, Palosuo K, Kukkonen K, Makela M, et al
    Molecular allergy diagnostics in predicting oral cow's milk challenge outcome in Finnish children.
    Allergy Asthma Proc. 2022 Nov 18. doi: 10.2500/aap.2023.44.220079.
    PubMed     Abstract available
    
    
    
97. SALAZAR PE, Habib N, Pasha MA
    2-Octyl cyanoacrylate, a hidden allergen, a common cause of postsurgical allergic contact dermatitis.
    Allergy Asthma Proc. 2022;43:529-532.
    PubMed     Abstract available
    
    
    
98. GULTUNA S
    Clinical characteristics of cat sensitized adults, cat ownership and cat owners' attitudes.
    Allergy Asthma Proc. 2022;43:e65-e71.
    PubMed     Abstract available
    
    
    
99. ALVES PB, Pereira HP, Alves MP, Roseta L, et al
    Predictors of anaphylaxis to peanut and tree nuts in a Mediterranean population.
    Allergy Asthma Proc. 2022;43:533-542.
    PubMed     Abstract available
    
    
    
100. BELLANTI JA, Settipane RA
     A confluence of advanced treatment options for atopic dermatitis, eosinophilic lung diseases and chronic urticaria brought about by the revolutionary discovery of biologics and Janus kinase inhibitors.
     Allergy Asthma Proc. 2022;43:471-473.
     PubMed    
     
     
     
101. GRISCTI SOLER D, Bennici A, Brunetto S, Gangemi S, et al
     Benralizumab in the management of rare primary eosinophilic lung diseases.
     Allergy Asthma Proc. 2022;43:494-500.
     PubMed     Abstract available
     
     
     
102. GROSS LM, Nelson HS, Khatiwada A, Hoyte FCL, et al
     Curcumin does not significantly affect immediate skin tests.
     Allergy Asthma Proc. 2022;43:543-545.
     PubMed     Abstract available
     
     
     
103. OZTOP N, Demir S, Unal D, Beyaz S, et al
     Predictive factors of recurrence after omalizumab cessation in the elderly with urticaria: A real-life study.
     Allergy Asthma Proc. 2022;43:519-528.
     PubMed     Abstract available
     
     
     
104. WALLACE DV
     Treatment options for moderate to severe atopic dermatitis.
     Allergy Asthma Proc. 2022;43:474-493.
     PubMed     Abstract available
     
     
     
105. FRENKEL LD, Bellanti JA
     Monkeypox viral infection and disease: A challenge for the allergist-immunologist.
     Allergy Asthma Proc. 2022;43:509-518.
     PubMed     Abstract available
     
     
     
106. NELSON HS
     The return of the mixed respiratory bacterial vaccine.
     Allergy Asthma Proc. 2022;43:501-508.
     PubMed     Abstract available
     
     
     
107. OZTOP N, Demir S, Toprak ID, Unal D, et al
     Positive perception of COVID-19 vaccination in HAE: No significant impact of vaccination on disease course.
     Allergy Asthma Proc. 2022;43:546-554.
     PubMed     Abstract available
     
     
     
108. 
     Abstracts presented at the Eastern Allergy Conference, June 2-5, 2022, Palm Beach, Florida.
     Allergy Asthma Proc. 2022;43:560-567.
     PubMed    
     
     
     September 2022
109. BOUILLET L, Fain O, Armengol G, Aubineau M, et al
     Long-term prophylaxis in hereditary angioedema management: Current practices in France and unmet needs.
     Allergy Asthma Proc. 2022;43:406-412.
     PubMed     Abstract available
     
     
     
110. FONACIER L, Banta E, Mawhirt S, Noor I, et al
     Capturing total steroid burden in patients with atopic dermatitis and asthma.
     Allergy Asthma Proc. 2022;43:454-460.
     PubMed     Abstract available
     
     
     
111. NORRIS M, Ashoor Z, Craig T
     Management of pediatric hereditary angioedema types 1 and 2: A search for international consensus.
     Allergy Asthma Proc. 2022;43:388-396.
     PubMed     Abstract available
     
     
     
112. KESH S, Singh U, Bernstein JA
     Longitudinal experience with treatment of acquired angioedema using tranexamic acid.
     Allergy Asthma Proc. 2022;43:413-418.
     PubMed     Abstract available
     
     
     
113. MAMYRBEKOVA S, Iskakova G, Faizullina K, Kuziyeva G, et al
     The diagnostic accuracy of spirometry versus peak expiratory flow test for follow-up of adult asthma patients at primary care level.
     Allergy Asthma Proc. 2022;43:e58-e64.
     PubMed     Abstract available
     
     
     
114. BUYUK YAYTOKGIL S, Metbulut AP, Ginis T, Toyran M, et al
     Cat allergy in children and the effect of the COVID-19 pandemic.
     Allergy Asthma Proc. 2022;43:e31-e39.
     PubMed     Abstract available
     
     
     
115. WANGBERG H, Mortazavi D, Kitsen J, Sanni A, et al
     Dose-dependent association between inhaled corticosteroid use and risk of obesity and metabolic syndrome in asthma.
     Allergy Asthma Proc. 2022;43:446-453.
     PubMed     Abstract available
     
     
     
116. TAUNK ST, Cardet JC, Ledford DK
     Clinical implications of asthma endotypes and phenotypes.
     Allergy Asthma Proc. 2022;43:375-382.
     PubMed     Abstract available
     
     
     
117. ZHANG S, Fu Q, Wang S, Jin X, et al
     Association between air pollution and the prevalence of allergic rhinitis in Chinese children: A systematic review and meta-analysis.
     Allergy Asthma Proc. 2022;43:e47-e57.
     PubMed     Abstract available
     
     
     
118. PETERS AT, Bengtson LGS, Chung Y, Emmanuel B, et al
     Clinical and economic burden of chronic rhinosinusitis with nasal polyposis: A U.S. administrative claims analysis.
     Allergy Asthma Proc. 2022;43:435-445.
     PubMed     Abstract available
     
     
     
119. BELLANTI JA
     The long COVID syndrome: A conundrum for the allergist/immunologist.
     Allergy Asthma Proc. 2022;43:368-374.
     PubMed     Abstract available
     
     
     
120. BELLANTI JA, Settipane RA
     Asthma biomarkers and COVID-19 continue to dominate current medical issues.
     Allergy Asthma Proc. 2022;43:363-367.
     PubMed    
     
     
     
121. KADDIS T, Joshi S, Anstey KM
     Efficacy and safety of an e-consult program for COVID-19 vaccine allergy concerns.
     Allergy Asthma Proc. 2022;43:431-434.
     PubMed     Abstract available
     
     
     
122. KOIZUMI M, Kuzume K, Ishida Y, Midoro-Horiuti T, et al
     Serum thymus and activation-regulated chemokine (TARC) levels correlate with atopic dermatitis disease severity in patients < 6 months.
     Allergy Asthma Proc. 2022;43:461-467.
     PubMed     Abstract available
     
     
     
123. RIEDL MA, Neville D, Cloud B, Desai B, et al
     Shared decision-making in the management of hereditary angioedema: An analysis of patient and physician perspectives.
     Allergy Asthma Proc. 2022;43:397-405.
     PubMed     Abstract available
     
     
     July 2022
124. CHOI YJ, Seong S, Lee KS, Lee K, et al
     Effects of mechanical washing and drying on the removal of pet allergens.
     Allergy Asthma Proc. 2022 Jul 25. doi: 10.2500/aap.2022.43.220029.
     PubMed     Abstract available
     
     
     
125. SENGUL EMEKSIZ Z, Yilmaz D, Alan B, Tunc SD, et al
     Clinical utility of serum tryptase levels in pediatric anaphylaxis.
     Allergy Asthma Proc. 2022 Jul 1. doi: 10.2500/aap.2022.43.220042.
     PubMed     Abstract available
     
     
     
126. PENAGOS M, Durham SR
     Long-term efficacy of the sublingual and subcutaneous routes in allergen immunotherapy.
     Allergy Asthma Proc. 2022;43:292-298.
     PubMed     Abstract available
     
     
     
127. BELLANTI JA, Settipane RA, DuBuske L
     Essentials of allergen immunotherapy: A primer for the practitioner.
     Allergy Asthma Proc. 2022;43:245-247.
     PubMed     Abstract available
     
     
     
128. NELSON HS
     Future directions in allergen immunotherapy.
     Allergy Asthma Proc. 2022;43:356-362.
     PubMed     Abstract available
     
     
     
129. GREIWE J, Bernstein JA
     Accelerated/rush allergen immunotherapy.
     Allergy Asthma Proc. 2022;43:344-349.
     PubMed     Abstract available
     
     
     
130. LARENAS-LINNEMANN D
     Long-term adherence strategies for allergen immunotherapy.
     Allergy Asthma Proc. 2022;43:299-304.
     PubMed     Abstract available
     
     
     
131. WEBER RW
     Assessing cross-reactivity in allergen immunotherapy.
     Allergy Asthma Proc. 2022;43:314-321.
     PubMed     Abstract available
     
     
     
132. TAN TJ, Layhadi JA, Shamji MH
     Mechanisms and biomarkers of subcutaneous immunotherapy and sublingual immunotherapy in allergen immunotherapy.
     Allergy Asthma Proc. 2022;43:254-259.
     PubMed     Abstract available
     
     
     
133. BERNSTEIN DI, Epstein TG
     Safety of subcutaneous allergen immunotherapy.
     Allergy Asthma Proc. 2022;43:267-271.
     PubMed     Abstract available
     
     
     
134. FINEGOLD I
     A brief history of allergen immunotherapy.
     Allergy Asthma Proc. 2022;43:248-253.
     PubMed     Abstract available
     
     
     
135. TANKERSLEY M
     Current concepts in optimized construction of allergen immunotherapy vaccines: Practical implications.
     Allergy Asthma Proc. 2022;43:322-326.
     PubMed     Abstract available
     
     
     
136. CALDERON MA, Demoly P
     Integrating the evidence in allergen immunotherapy: Why real-world data should be important for the practicing clinician?
     Allergy Asthma Proc. 2022;43:305-309.
     PubMed     Abstract available
     
     
     
137. GOLDEN DBK
     Venom allergen immunotherapy.
     Allergy Asthma Proc. 2022;43:339-343.
     PubMed     Abstract available
     
     
     
138. PARASHAR S, Pandya A, Portnoy JM
     Pediatric subcutaneous allergen immunotherapy.
     Allergy Asthma Proc. 2022;43:286-291.
     PubMed     Abstract available
     
     
     
139. CRETICOS PS
     Subcutaneous allergen immunotherapy in the treatment of allergic respiratory disease.
     Allergy Asthma Proc. 2022;43:260-266.
     PubMed     Abstract available
     
     
     
140. SUBLETT JL
     United States Pharmacopeia guidance for compounding of allergenic extracts for allergen immunotherapy.
     Allergy Asthma Proc. 2022;43:333-338.
     PubMed     Abstract available
     
     
     
141. BLAISS MS
     Pediatric sublingual allergen immunotherapy.
     Allergy Asthma Proc. 2022;43:281-285.
     PubMed     Abstract available
     
     
     
142. DUBUSKE L
     Efficacy and safety of sublingual allergen immunotherapy.
     Allergy Asthma Proc. 2022;43:272-280.
     PubMed     Abstract available
     
     
     
143. CAIMMI D, Demoly P
     A review of allergen immunotherapy in asthma.
     Allergy Asthma Proc. 2022;43:310-313.
     PubMed     Abstract available
     
     
     
144. NELSON HS
     Standardized allergen extracts for allergen immunotherapy.
     Allergy Asthma Proc. 2022;43:327-332.
     PubMed     Abstract available
     
     
     
145. SETTIPANE RA, Bukstein DA
     Allergen immunotherapy and shared decision-making.
     Allergy Asthma Proc. 2022;43:350-355.
     PubMed     Abstract available
     
     
     June 2022
146. KHAN NS, Rubin E, McKenna B, Sonnenberg F, et al
     Biomarker underuse contributes to an inability to phenotype patients with severe uncontrolled asthma.
     Allergy Asthma Proc. 2022 Jun 27. doi: 10.2500/aap.2022.43.220038.
     PubMed     Abstract available
     
     
     May 2022
147. BEYAZ S, Ersoy Y, Bicki E, Ak T, et al
     Psychiatric comorbidity and quality of life in patients with drug hypersensitivity.
     Allergy Asthma Proc. 2022;43:234-242.
     PubMed     Abstract available
     
     
     
148. BELLANTI JA, Settipane RA
     Eosinophilic esophagitis: from discovery to effective treatment.
     Allergy Asthma Proc. 2022;43:175-177.
     PubMed    
     
     
     
149. CRAIG T, Feuersenger H, Pragst I, Dang J, et al
     Prophylactic therapy with subcutaneous C1-inhibitor is associated with sustained symptom control in patients with hereditary angioedema.
     Allergy Asthma Proc. 2022;43:202-208.
     PubMed     Abstract available
     
     
     
150. SHER ER, Ross JA, Weine DM, Chandini Arjun A, et al
     Current and emerging therapies for eosinophilic esophagitis.
     Allergy Asthma Proc. 2022;43:178-186.
     PubMed     Abstract available
     
     
     
151. LANG A, Balmert LC, Weiss M, Pongracic JA, et al
     Real world use of peanut component testing among children in the Chicago metropolitan area.
     Allergy Asthma Proc. 2022;43:226-233.
     PubMed     Abstract available
     
     
     
152. CAN BOSTAN O, Cakmak ME, Kaya SB, Tuncay G, et al
     The association of timothy grass allergy and cat ownership on cat sensitization.
     Allergy Asthma Proc. 2022;43:220-225.
     PubMed     Abstract available
     
     
     
153. DENG SJ, Wang J, Liu L, Zhang X, et al
     Chronic cough in asthma is associated with increased airway inflammation, more comorbidities, and worse clinical outcomes.
     Allergy Asthma Proc. 2022;43:209-219.
     PubMed     Abstract available
     
     
     March 2022
154. 
     Abstracts presented at the Western Society of Allergy, Asthma & Immunology, Annual Scientific Session, February 6-10, 2022, Maui, Hawaii.
     Allergy Asthma Proc. 2022;43:174.
     PubMed    
     
     
     
155. DIEHL KC, Popadiuk CA, Agbese E, Leslie DL, et al
     Cost assessment of allergy procedures to improve high-value care implementation.
     Allergy Asthma Proc. 2022;43:168-172.
     PubMed     Abstract available
     
     
     
156. VOELKER DH, Gonzalez-Estrada A, Park MA
     Female sex as a risk factor for penicillin drug allergy in the inpatient setting.
     Allergy Asthma Proc. 2022;43:163-167.
     PubMed     Abstract available
     
     
     
157. RAMIREZ RM, Jacobs RL, Andrews CP
     Birch-naive, oak-allergic subjects' response to birch pollen in an environmental chamber.
     Allergy Asthma Proc. 2022;43:116-123.
     PubMed     Abstract available
     
     
     
158. BELLANTI JA, Settipane RA
     Long-COVID and loss of smell: A post-COVID olfactory dysfunction that continues to challenge the allergist/immunologist.
     Allergy Asthma Proc. 2022;43:93-95.
     PubMed    
     
     
     
159. CHEPY A, Veron M, Gautier S, Farhat MM, et al
     Initial characteristics and follow-up of patients with a diagnosis of angiotensin-converting enzyme inhibitor induced angioedema.
     Allergy Asthma Proc. 2022;43:155-162.
     PubMed     Abstract available
     
     
     
160. BEYAZ S, Demir S, Oztop N, Colakoglu B, et al
     How satisfactory is on-demand icatibant from the patients' perspective in real life?
     Allergy Asthma Proc. 2022;43:148-154.
     PubMed     Abstract available
     
     
     
161. OZDEN SERTCELIK U, Damadoglu E, Karakaya G, Demir AU, et al
     Impact of socioeconomic factors and house cleaning on asthma control in women.
     Allergy Asthma Proc. 2022;43:140-147.
     PubMed     Abstract available
     
     
     
162. KIM HS, Yang HJ, Song DJ, Lee YJ, et al
     Eosinophil-derived neurotoxin: An asthma exacerbation biomarker in children.
     Allergy Asthma Proc. 2022;43:133-139.
     PubMed     Abstract available
     
     
     
163. WU G, Hu H, Zhang T, Zhang XD, et al
     Profiles of sensitization and comorbidity in asthma patients with markedly increased serum total IgE (>1000kU/L).
     Allergy Asthma Proc. 2022;43:124-132.
     PubMed     Abstract available
     
     
     January 2022
164. MALLIORI S, Ntzounas A, Lampropoulos P, Koliofoti E, et al
     Diverging trends of respiratory allergies and eczema in Greek schoolchildren: Six surveys during 1991-2018.
     Allergy Asthma Proc. 2022;43:e17-e24.
     PubMed     Abstract available
     
     
     
165. 
     Abstracts presented at the Eastern Allergy Conference, June 3-6, 2021, Palm Beach, Florida.
     Allergy Asthma Proc. 2022;43:86-90.
     PubMed    
     
     
     
166. HARADA K, Baker MG, Agarwal S
     Patient perspectives on penicillin allergy and testing.
     Allergy Asthma Proc. 2022;43:64-69.
     PubMed     Abstract available
     
     
     
167. BUYUK YAYTOKGIL S, Kulhas Celik I, Karaatmaca B, Ginis T, et al
     Prognosis of food-induced anaphylaxis in children: A single-center real-life study.
     Allergy Asthma Proc. 2022;43:57-63.
     PubMed     Abstract available
     
     
     
168. SERBES M, Sasihuseyinoglu AS, Ozcan D, Ufuk Altintas D, et al
     Clinical features of anaphylaxis in children.
     Allergy Asthma Proc. 2022;43:50-56.
     PubMed     Abstract available
     
     
     
169. ALMODALLAL Y, Weaver AL, Joshi AY
     Population-based incidence of food allergies in Olmsted County over 17 years.
     Allergy Asthma Proc. 2022;43:44-49.
     PubMed     Abstract available
     
     
     
170. AQUINO MR, Bingemann TA, Nanda A, Maples KM, et al
     Delayed allergic skin reactions to vaccines.
     Allergy Asthma Proc. 2022;43:20-29.
     PubMed     Abstract available
     
     
     
171. YOUSEF E, Korotkaya Y, Simpson AB
     Eosinophilic esophagitis in children: Updates and practical aspects of management for allergists in a non-tertiary care private practice setup.
     Allergy Asthma Proc. 2022;43:5-11.
     PubMed     Abstract available
     
     
     
172. GRIVCHEVA-PANOVSKA V, Craig TJ, Longhurst H, Bara N, et al
     Global perceptions of the current and future impacts of COVID-19 on hereditary angioedema management.
     Allergy Asthma Proc. 2022;43:e1-e10.
     PubMed     Abstract available
     
     
     
173. PITLICK MM, Joshi AY, Gonzalez-Estrada A, Chiarella SE, et al
     Delayed systemic urticarial reactions following mRNA COVID-19 vaccination.
     Allergy Asthma Proc. 2022;43:40-43.
     PubMed     Abstract available
     
     
     
174. GALLAGHER MC, Haessler S, Pecoy-Whitcomb E, Bayuk J, et al
     Monitored COVID-19 mRNA vaccine second doses for people with adverse reactions after the first dose.
     Allergy Asthma Proc. 2022;43:37-39.
     PubMed     Abstract available
     
     
     
175. MAGEN E, Yakov A, Green I, Israel A, et al
     Chronic spontaneous urticaria after BNT162b2 mRNA (Pfizer-BioNTech) vaccination against SARS-CoV-2.
     Allergy Asthma Proc. 2022;43:30-36.
     PubMed     Abstract available
     
     
     
176. GANTI P, Suman A, Chaudhary S, Sangha B, et al
     The effect of the socioeconomic status on the measurement of asthma control.
     Allergy Asthma Proc. 2022;43:e11-e16.
     PubMed     Abstract available
     
     
     
177. MCMURRAY JC, Clair BS, Spriet SW, Min SB, et al
     Outcomes of eosinophilic esophagitis in patients managed in a multidisciplinary clinic.
     Allergy Asthma Proc. 2022;43:78-84.
     PubMed     Abstract available
     
     
     
178. RADOJICIC C
     Guidelines for management of hereditary angioedema: What is new? What is missing?
     Allergy Asthma Proc. 2022;43:12-19.
     PubMed     Abstract available
     
     
     November 2021
179. DEMIRHAN A, Yildirim DD, Arikoglu T, Ozhan AK, et al
     A combined risk modeling strategy for clinical prediction of beta-lactam allergies in children.
     Allergy Asthma Proc. 2021;42:e159-e166.
     PubMed     Abstract available
     
     
     
180. VEZIR E, Hizal M, Cura Yayla B, Aykac K, et al
     Does aeroallergen sensitivity and allergic rhinitis in children cause milder COVID-19 infection?
     Allergy Asthma Proc. 2021;42:522-529.
     PubMed     Abstract available
     
     
     
181. PATEL GB, Chhiba KD, Chen MM, Guo A, et al
     COVID-19 vaccine-related presumed allergic reactions and second dose administration by using a two-step graded protocol.
     Allergy Asthma Proc. 2021;42:515-521.
     PubMed     Abstract available
     
     
     
182. BURROWS AG, Ellis AK
     Idiopathic anaphylaxis: Diagnosis and management.
     Allergy Asthma Proc. 2021;42:481-488.
     PubMed     Abstract available
     
     
     
183. VERONEZ CL, Christiansen SC, Smith TD, Riedl MA, et al
     COVID-19 and hereditary angioedema: Incidence, outcomes, and mechanistic implications.
     Allergy Asthma Proc. 2021;42:506-514.
     PubMed     Abstract available
     
     
     
184. PAN R, Li Q, Zhu X, Zhou Y, et al
     Diagnostic value of YKL-40 for patients with asthma: A meta-analysis.
     Allergy Asthma Proc. 2021;42:e167-e173.
     PubMed     Abstract available
     
     
     
185. OLGAC M, Guler SD, Demir S, Unal D, et al
     Paucigranulocytic asthma: Do sputum macrophages matter?
     Allergy Asthma Proc. 2021;42:530-536.
     PubMed     Abstract available
     
     
     
186. BLAISS M, Berger W, Chipps B, Hernandez-Trujillo V, et al
     Safety of ciclesonide in children with asthma: A review of randomized controlled trials.
     Allergy Asthma Proc. 2021;42:471-480.
     PubMed     Abstract available
     
     
     
187. BLAISS M, Berger W, Chipps B, Hernandez-Trujillo V, et al
     Review of efficacy of ciclesonide for the treatment of asthma in children.
     Allergy Asthma Proc. 2021;42:461-470.
     PubMed     Abstract available
     
     
     
188. WALLACE DV
     Treatment options for chronic rhinosinusitis with nasal polyps.
     Allergy Asthma Proc. 2021;42:450-460.
     PubMed     Abstract available
     
     
     September 2021
189. SARIOGLU N, Yalcin AD, Sahin F, Soyyigit S, et al
     Does vitamin D deficiency in asthma affect clinical and functional parameters? A Turkish multicenter study.
     Allergy Asthma Proc. 2021;42:e152-e158.
     PubMed     Abstract available
     
     
     
190. XU H, Gao Y, Xie Y, Liang X, et al
     Bronchial provocation test measured by using the forced oscillation technique to assess airway responsiveness.
     Allergy Asthma Proc. 2021;42:e127-e134.
     PubMed     Abstract available
     
     
     
191. KOCHIS S, Keet C, Claus LE, Hairston T, et al
     Caregiver perceptions and attitudes associated with oral immunotherapy on social media.
     Allergy Asthma Proc. 2021;42:432-438.
     PubMed     Abstract available
     
     
     July 2021
192. DZIEWA I, Hahn T, Bhardwaj N
     Persistent urticarial rash in a newborn.
     Allergy Asthma Proc. 2021;42:357-361.
     PubMed     Abstract available
     
     
     
193. MANNING ME, Kashkin JM
     Berotralstat (BCX7353) is a novel oral prophylactic treatment for hereditary angioedema: Review of phase II and III studies.
     Allergy Asthma Proc. 2021;42:274-282.
     PubMed     Abstract available
     
     
     
194. ZHU WJ, Liu Y, Wang G, Deng K, et al
     Interaction effects of asthma and rhinitis control on work productivity and activity impairment: A cross-sectional study.
     Allergy Asthma Proc. 2021 Jul 14. doi: 10.2500/aap.2021.42.210052.
     PubMed     Abstract available
     
     
     
195. OCAK M, Akarsu A, Sahiner UM, Soyer O, et al
     Food protein-induced enterocolitis syndrome: Current practices in oral food challenge.
     Allergy Asthma Proc. 2021;42:343-349.
     PubMed     Abstract available
     
     
     
196. OCAK M, Nain E, Akarsu A, Sahiner UM, et al
     Health-related quality of life in children with hereditary angioedema compared with patients with histaminergic angioedema.
     Allergy Asthma Proc. 2021;42:325-332.
     PubMed     Abstract available
     
     
     
197. JOHNSON FA, Wirth M, Zhu Z, Hahn J, et al
     Etiology and predictors of cluster attacks of hereditary angioedema that recur despite pharmaceutical treatment.
     Allergy Asthma Proc. 2021;42:317-324.
     PubMed     Abstract available
     
     
     
198. KWONG KY, Lu YZ, Jauregui E, Scott L, et al
     Persistent airflow obstruction in inner-city children with asthma.
     Allergy Asthma Proc. 2021;42:310-316.
     PubMed     Abstract available
     
     
     May 2021
199. ALZAABI A, Idrees M, Behbehani N, Salah F, et al
     Patients' and physicians' attitudes and perception about asthma in the Gulf: A subset analysis from the Asthma Insights and Management Survey in the Gulf and Russia.
     Allergy Asthma Proc. 2021;42:e77-e85.
     PubMed     Abstract available
     
     
     
200. VAN ZELST CM, de Boer GM, Turk Y, van Huisstede A, et al
     Association between elevated serum triglycerides and asthma in patients with obesity: An explorative study.
     Allergy Asthma Proc. 2021;42:e71-e76.
     PubMed     Abstract available
     
     
     
201. AJEWOLE O, Lanlokun M, Dimanche S, Craig T, et al
     Short-term prophylaxis for children and adolescents with hereditary angioedema.
     Allergy Asthma Proc. 2021;42:205-213.
     PubMed     Abstract available
     
     
     
202. ZHANG S, Bernstein JA
     Mast cell activation syndrome: Myths and realities.
     Allergy Asthma Proc. 2021;42:198-204.
     PubMed     Abstract available
     
     
     
203. RIEDL MA, Craig TJ, Banerji A, Aggarwal K, et al
     Physician and patient perspectives on the management of hereditary angioedema: a survey on treatment burden and needs.
     Allergy Asthma Proc. 2021;42:S17-S25.
     PubMed     Abstract available
     
     
     
204. CRAIG TJ, Banerji A, Riedl MA, Best JM, et al
     Caregivers' role in managing hereditary angioedema and perceptions of treatment-related burden.
     Allergy Asthma Proc. 2021;42:S11-S16.
     PubMed     Abstract available
     
     
     
205. RADOJICIC C, Riedl MA, Craig TJ, Best JM, et al
     Patient perspectives on the treatment burden of injectable medication for hereditary angioedema.
     Allergy Asthma Proc. 2021;42:S4-S10.
     PubMed     Abstract available
     
     
     
206. BANERJI A, Riedl MA, Craig TJ, Radojicic C, et al
     Insights into the treatment burden of hereditary angioedema in the evolving treatment landscape.
     Allergy Asthma Proc. 2021;42:S1-S3.
     PubMed    
     
     
     March 2021
207. WANG Q, Pittman L, Healey A, Chang J, et al
     Ideal body position for epinephrine autoinjector administration.
     Allergy Asthma Proc. 2021;42:147-152.
     PubMed     Abstract available
     
     
     
208. CASTALDO AJ, Jervelund C, Corcoran D, Boysen HB, et al
     Assessing the cost and quality-of-life impact of on-demand-only medications for adults with hereditary angioedema.
     Allergy Asthma Proc. 2021;42:108-117.
     PubMed     Abstract available
     
     
     
209. 
     For the patient.
     Allergy Asthma Proc. 2021;42:180.
     PubMed    
     
     
     
210. GENEROSO AJ, Goldman JA, Wolff AH
     A 62-year-old man with new-onset bullae.
     Allergy Asthma Proc. 2021;42:175-179.
     PubMed     Abstract available
     
     
     
211. BUYUK YAYTOKGIL S, Guvenir H, Kulhas Celik I, Yilmaz Topal O, et al
     Evaluation of drug patch tests in children.
     Allergy Asthma Proc. 2021;42:167-174.
     PubMed     Abstract available
     
     
     
212. COHEN JS, Agbim C, Hrdy M, Mottla ME, et al
     Epinephrine autoinjector prescription filling after pediatric emergency department discharge.
     Allergy Asthma Proc. 2021;42:142-146.
     PubMed     Abstract available
     
     
     
213. SWEIS AM, Locke TB, Ig-Izevbekhai KI, Lin TC, et al
     Effectiveness of endoscopic sinus surgery and aspirin therapy in the management of aspirin-exacerbated respiratory disease.
     Allergy Asthma Proc. 2021;42:136-141.
     PubMed     Abstract available
     
     
     
214. CAO Y, Liu S, Zhi Y
     Recurrent and acute abdominal pain as the main clinical manifestation in patients with hereditary angioedema.
     Allergy Asthma Proc. 2021;42:131-135.
     PubMed     Abstract available
     
     
     
215. ANAGNOSTOU A
     Weighing the benefits and risks of oral immunotherapy in clinical practice.
     Allergy Asthma Proc. 2021;42:118-123.
     PubMed     Abstract available
     
     
     
216. BELLANTI JA, Settipane RA
     Hereditary angioedema again revisited.
     Allergy Asthma Proc. 2021;42:105-107.
     PubMed    
     
     
     January 2021
217. YORMAZ B, Menevse E, Cetin N, Esin Celik Z, et al
     Diagnostic value of thymus and activation-regulated chemokine and of periostin in eosinophilic asthma: A prospective study.
     Allergy Asthma Proc. 2021;42:e30-e39.
     PubMed     Abstract available
     
     
     
218. TASHKIN DP, Koltun A, Wallace R
     A generic fluticasone propionate and salmeterol dry powder inhaler: Evidence of usability, function, and robustness.
     Allergy Asthma Proc. 2021;42:30-35.
     PubMed     Abstract available
     
     
     
219. JOHNSTON DT, Henry Li H, Craig TJ, Bernstein JA, et al
     Androgen use in hereditary angioedema: A critical appraisal and approaches to transitioning from androgens to other therapies.
     Allergy Asthma Proc. 2021;42:22-29.
     PubMed     Abstract available
     
     
     
220. OZDEN MAT D, Firat S, Aksu K, Aksu F, et al
     Obstructive sleep apnea is a determinant of asthma control independent of smoking, reflux, and rhinitis.
     Allergy Asthma Proc. 2021;42:e25-e29.
     PubMed     Abstract available
     
     
     
221. MAGEN E, Waitman DA, Kahan NR
     Hematologic parameters as biomarkers for antihistamine and omalizumab resistance in chronic spontaneous urticaria.
     Allergy Asthma Proc. 2021;42:e17-e24.
     PubMed     Abstract available
     
     
     
222. TIOTIU A
     Applying personalized medicine to adult severe asthma.
     Allergy Asthma Proc. 2021;42:e8-e16.
     PubMed     Abstract available
     
     
     
223. SAVARESE L, Mormile I, Bova M, Petraroli A, et al
     Psychology and hereditary angioedema: A systematic review.
     Allergy Asthma Proc. 2021;42:e1-e7.
     PubMed     Abstract available
     
     
     
224. AYDIN O, Sozener ZC, Demirel YS, Secil D, et al
     Baker's asthma in bread factory workers.
     Allergy Asthma Proc. 2021;42:72-77.
     PubMed     Abstract available
     
     
     
225. DUDIAK GJ, Popyack J, Grimm C, Tyson S, et al
     Prior authorization delays biologic initiation and is associated with a risk of asthma exacerbations.
     Allergy Asthma Proc. 2021;42:65-71.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Hypersensitivity Reaction is free of charge.